Falls Are the Leading Danger for Older Adults — Does THC Make It Worse?

Every year, approximately 684,000 people die from fall-related injuries worldwide, and older adults account for the vast majority of these deaths. For adults aged 65 and older, a single fall can trigger a cascade of consequences — fractures, hospitalization, loss of independence, and declining health. At the same time, cannabis use among older adults is rising sharply. Studies show that adults aged 65 and above represent one of the fastest-growing groups of cannabis consumers, often using it to manage pain, anxiety, or sleep problems.

This overlap raises an important clinical question: does THC — the main psychoactive compound in cannabis — increase the risk of falling in older adults? The answer has real consequences for patients, caregivers, and healthcare providers. This article reviews the current evidence, explains the relevant biology, and offers practical context to help inform safer decisions.

Why Falls Are So Dangerous for Older Adults

Falls represent one of the most serious public health challenges facing aging populations worldwide. According to the World Health Organization (WHO), falls are the second leading cause of accidental injury deaths globally, with adults aged 65 and older accounting for the greatest share of fall-related fatalities and hospitalizations. Each year, approximately 684,000 people die from falls worldwide, and older adults suffer around 37.3 million falls severe enough to require medical attention. In the United States alone, one in four older adults falls annually, resulting in more than 3 million emergency department visits. The economic burden is equally staggering — fall-related injuries cost the U.S. healthcare system over $50 billion per year, with similar proportional costs reported across Europe and Asia-Pacific nations.

Several physiological changes associated with normal aging make older adults especially vulnerable. Muscle mass declines steadily after age 50, a process called sarcopenia, which weakens the legs and core muscles needed to maintain stability. Bone density also decreases — particularly in women after menopause — meaning that a fall is far more likely to cause a fracture than it would in a younger person. Balance depends heavily on a sense called proprioception (the body’s ability to detect its own position in space), which deteriorates with age. Reflexes also slow down, reducing the ability to catch oneself before hitting the ground.

Many older adults also take multiple medications simultaneously — a situation known as polypharmacy — which can further impair balance, cause dizziness, or lower blood pressure upon standing.

The consequences of falls are severe. Hip fractures, which occur in approximately 300,000 older Americans annually, often require surgery and prolonged rehabilitation. Traumatic brain injuries from falls can be life-altering. Perhaps most significantly, falls frequently trigger a loss of independence that profoundly affects quality of life.

Key Fall Statistics in Adults 65+ by Region

The following table summarizes fall-related incidence, hospitalization, and mortality rates across major global regions for adults aged 65 and older.

These figures underscore the scale and severity of fall-related harm among older adults across all major world regions.

Cannabis Use Trends Among Older Adults

Cannabis use among adults aged 65 and older has risen sharply over the past decade. Data from the U.S. National Survey on Drug Use and Health (NSDUH) show that past-year cannabis use in this age group increased from roughly 2.4% in 2015 to over 7% by 2022 — nearly tripling within seven years. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reports reflect similar upward trends across several EU member states. Post-legalization jurisdictions, particularly U.S. states such as Colorado and California, recorded especially steep increases, suggesting that legal access meaningfully lowers barriers for older users.

Older adults turn to cannabis for several practical reasons, most often related to managing conditions that conventional medications handle imperfectly.

The following table outlines the most commonly reported motivations for cannabis use among older adults.

Within older adult populations, CBD (cannabidiol — the non-intoxicating compound) is often preferred over THC (tetrahydrocannabinol — the compound that produces psychoactive effects). However, many commercially available products contain both. Despite rising use rates, geriatric-specific clinical research on cannabis safety remains seriously limited, leaving physicians without reliable, age-focused guidance.

How THC Affects the Body: Mechanisms Relevant to Fall Risk

THC (tetrahydrocannabinol) is the main psychoactive compound in cannabis. To understand its connection to fall risk, it helps to know how it works inside the body.

THC interacts with the endocannabinoid system (ECS) — a network of receptors found throughout the brain, nervous system, and body. This system naturally helps regulate mood, pain, movement, and balance. THC mimics the body’s own chemical messengers and binds to ECS receptors, particularly in brain regions that control coordination and motor function. This disruption produces several effects directly relevant to falling.

Key pharmacological effects include:

• Psychomotor impairment — THC slows reaction time, meaning the brain takes longer to respond to a sudden loss of balance.
• Sedation and dizziness — Cannabis commonly causes drowsiness and lightheadedness, both of which increase stumbling risk.
• Orthostatic hypotension — This is a sudden drop in blood pressure when standing up. THC can trigger this response, causing momentary faintness.
• Impaired coordination and proprioception — Proprioception is the body’s sense of its own position in space. THC disrupts this awareness, making steady movement harder.

Older adults are especially vulnerable to these effects for several biological reasons. First, the liver processes drugs more slowly with age (reduced hepatic clearance), so THC stays in the system longer. Second, ECS receptors become more sensitive over time, amplifying THC’s effects. Third, many older adults have less prior cannabis experience, meaning lower baseline tolerance.

The delivery method also matters. Inhaled THC reaches the bloodstream within minutes, while edibles can take one to two hours to peak. This delay often leads older users to consume more than intended, resulting in unexpectedly strong effects.

THC Pharmacokinetic Profile — Younger Adults vs. Older Adults

The following table compares how THC behaves in the bodies of younger adults versus older adults across several key pharmacokinetic factors.

These pharmacokinetic differences highlight why older adults experience THC’s effects more intensely and for longer durations than their younger counterparts.

What Does the Research Say? THC and Fall Risk in Older Adults

The scientific community has increasingly turned its attention to cannabis use among older populations, and several important studies have begun to clarify — though not fully resolve — the relationship between THC and fall risk.

Observational and Cohort Studies

Observational studies, which track real-world patterns without controlling what participants do, have consistently identified a link between cannabis use and fall-related emergency department visits. A 2021 analysis using U.S. emergency department data found that older adults who reported cannabis use had notably higher rates of fall-related injuries compared to non-users. Similarly, a Canadian cohort study examining injury hospitalizations found that cannabis-related incidents disproportionately involved adults over 65, with falls representing the most common mechanism of injury.

Randomized controlled trials (RCTs) — the gold standard for proving cause and effect — are very limited in this area, largely because ethical and legal constraints make it difficult to administer THC to elderly participants in controlled settings. The few small RCTs that exist suggest acute THC exposure does temporarily impair postural stability, but long-term causal conclusions remain difficult to draw.

Dose-Response and Acute vs. Chronic Use

Some evidence points to a dose-response relationship, meaning higher THC concentrations are associated with greater impairment of balance and coordination. Acute (short-term or first-time) use appears to carry more immediate risk than chronic (long-term, habitual) use, possibly because regular users develop some degree of physiological tolerance. However, tolerance does not eliminate fall risk entirely, particularly in older adults whose baseline balance is already compromised.

Confounding Factors

Interpreting this research requires caution. Several confounding factors — hidden variables that distort findings — complicate the evidence:

• Selection bias: Cannabis users may already have more pain conditions, sleep disorders, or mobility problems that independently elevate fall risk.
• Self-reporting limitations: Older adults may underreport cannabis use due to stigma.
• Product variability: THC potency varies enormously across strains, edibles, and delivery methods, making comparisons across studies difficult.

These confounding factors mean that study findings must be interpreted with appropriate caution rather than taken at face value.

Notably, some studies found no statistically significant increase in fall risk among older cannabis users, particularly when controlling for other medications and health conditions.

Summary of Key Studies on Cannabis Use and Fall Risk in Older Adults

The following table summarizes the design, findings, and limitations of the most relevant studies examining cannabis use and fall risk in older adults.

The overall state of evidence is best described as suggestive but not definitive. The research consistently points in the direction of elevated risk, but methodological limitations prevent firm causal conclusions at this stage.

Compounding Risk: THC and Polypharmacy in Older Adults

Most older adults take multiple medications daily. In fact, polypharmacy — defined as the regular use of five or more prescription drugs — is nearly universal among people over 65. This happens for understandable reasons: many older adults manage several chronic conditions simultaneously, including heart disease, arthritis, diabetes, anxiety, and chronic pain. Each condition may require its own medication, and those medications can interact with one another in ways that neither the patient nor the prescriber fully anticipates.

When THC enters this already complex picture, the risks multiply. THC is not pharmacologically neutral — it actively influences the central nervous system and the liver’s drug-processing enzymes, creating potentially dangerous interactions with several common drug classes.

The following table outlines the most clinically significant drug interactions involving THC in older adult patients.

A key mechanism behind several of these interactions involves CYP450 enzymes — liver proteins responsible for breaking down medications. THC inhibits certain CYP450 pathways, meaning other drugs are metabolized more slowly, causing their concentrations to rise to potentially harmful levels in the bloodstream.

Critically, many older adults self-administer cannabis without informing their physicians, and some clinicians remain undertrained in cannabis pharmacology. This knowledge gap leaves dangerous interactions undetected.

Protective Factors and Risk Reduction: What Can Be Done

Complete avoidance of cannabis is one option, but for many older adults managing chronic pain, anxiety, or sleep difficulties, abstinence is not a realistic or preferred choice. A more practical approach focuses on harm reduction — minimizing risk while respecting individual decisions.

Clinical Screening Recommendations

Healthcare providers play a central role in reducing fall-related harm. Three key steps matter most:

1. Routine disclosure: Cannabis use should be documented as part of every patient’s medical history, just like prescription medications.
2. Fall risk assessment: Tools such as the Timed Up and Go (TUG) test — which measures how long a person takes to stand, walk three meters, turn, and sit back down — can identify patients who are already at elevated fall risk before cannabis is added to their routine.
3. Medication reconciliation: Cannabis products must be reviewed alongside all other medications to identify dangerous interactions, particularly with sedatives or blood pressure drugs.

Implementing these three steps consistently can meaningfully reduce the likelihood of undetected fall risk in older cannabis users.

Practical Guidance for Older Adults Who Choose to Use Cannabis

Older adults are generally more sensitive to the effects of THC and may face increased risks related to balance, cognition, and cardiovascular function. The following precautions can help reduce potential harms.

• Start low, go slow: Begin with the lowest possible dose and increase only gradually.
• Choose CBD-dominant or low-THC products when therapeutic goals allow, as these carry lower impairment risk.
• Avoid cannabis before physical activity or any task requiring balance and coordination.
• Have someone present when trying a new product or dose for the first time.
• Consume while seated or lying down to reduce the risk of orthostatic hypotension (a sudden drop in blood pressure when standing up).

Following these practical steps can help older adults who choose to use cannabis do so with a meaningfully reduced risk of falling.

Practical Safety Guidelines for Older Adults Using THC-Containing Products

The following table contrasts recommended behaviors with behaviors that should be avoided when older adults use THC-containing cannabis products.

Healthcare providers should initiate proactive, non-judgmental conversations about cannabis use and actively monitor patients for signs of impairment during clinical visits, treating the topic with the same clinical seriousness as any other medication affecting balance and cognition.

The Role of CBD vs. THC: Is There a Safer Alternative?

THC (tetrahydrocannabinol) is the compound in cannabis that causes the “high” — and the balance and coordination problems linked to fall risk. CBD (cannabidiol) is different. It does not produce psychoactive effects and generally does not impair movement or reaction time at typical doses.

Current evidence suggests CBD carries a lower fall risk profile. It does not significantly affect psychomotor function — meaning it is less likely to slow reflexes or disrupt balance. However, at high doses, CBD may cause mild sedation, which still warrants careful consideration in older adults.

For goals like managing chronic pain or anxiety, CBD may offer therapeutic value without the same dangers associated with THC.

That said, important limitations exist. Many commercial CBD products are mislabeled, and some contain undisclosed THC levels. Lab-tested, pharmaceutical-grade products should always be prioritized when available.

Additionally, CBD inhibits CYP450 enzymes — the liver’s drug-processing system — meaning it can raise blood levels of common medications like blood thinners, increasing interaction risks.

THC vs. CBD — Relevant Effects for Older Adult Fall Risk

The following table compares THC and CBD across the features most relevant to fall risk in older adults.

While CBD appears to carry a lower fall risk profile than THC, it is not without its own safety considerations, particularly regarding drug interactions in older adults.

Gaps in Research and Future Directions

Current evidence on THC and fall risk in older adults remains incomplete. Several critical gaps limit confident clinical guidance. Most existing studies lack randomized controlled trials (carefully designed experiments that reduce bias) specifically enrolling adults aged 65 and older. Research populations are also predominantly Western, leaving insufficient data from diverse global communities. Additionally, cannabis studies rarely use standardized dosing definitions, making it difficult to compare findings across studies. Long-term follow-up data tracking fall outcomes over years is similarly limited.

Despite these gaps, promising directions are emerging. Prospective cohort studies — which follow participants forward in time — are currently underway. Researchers are exploring cannabis-specific fall prevention protocols tailored to older adults, and interest in geriatric-inclusive clinical trials is growing.

Most urgently, the field needs standardized reporting frameworks so that future studies produce comparable, high-quality evidence that clinicians worldwide can reliably use.

Conclusion

Current evidence points in a clear direction: THC, the primary intoxicating compound in cannabis, meaningfully increases fall risk in older adults through several interconnected physiological pathways — including impaired balance, slowed reaction time, dizziness, and altered depth perception. While the research base is still growing and some gaps remain, the existing data is strong enough to warrant serious clinical attention.

Older adults are not simply “older versions” of younger cannabis users. Age-related changes in metabolism, brain sensitivity, and body composition make them significantly more vulnerable to THC’s effects, often at doses that younger individuals tolerate without difficulty. When prescription medications enter the picture, the risks compound further, creating dangerous interactions that neither patients nor clinicians may immediately recognize.

The goal here is not to prohibit older adults from making their own choices, but to ensure those choices are fully informed. Open, honest conversations between patients and healthcare providers are essential. Better-designed research specifically targeting older populations is urgently needed.

Ultimately, cannabis risk assessment — including fall risk evaluation — should become a standard component of geriatric care. As cannabis use among older adults continues to rise globally, integrating this awareness into routine clinical practice is no longer optional; it is a patient safety imperative.